PubMed Central
metadata only
MYC in cancer: from undruggable target to clinical trials
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- c-Myc and downstream targets in the pathogenesis and treatment of cancer#676596
- c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis#1005584
- Ipilimumab and Imatinib Mesylate in Advanced Cancer#67880
- Targeting MYCN in Pediatric and Adult Cancers#250638
- MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma#862410
Record · ID 320805
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive